MTB OUTBREAK LOCAL LAB RESPONSE Chris Partington MT(ASCP) ACL MICROBIOLOGY LAB.

Slides:



Advertisements
Similar presentations
1 Psychology at AS & A2 Do young children experience problems later on if separated from their caregivers? Can we improve our memory? What attracts us.
Advertisements

Purpose of 2005 Guidelines Update and replace 1994 Mycobacterium tuberculosis infection control (IC) guidelines Further reduce threat to health-care workers.
Tuberculosis in Children: Prevention Module 10C - March 2010.
World Health Organization TB Case Definitions
MDCH STATE LABORATORY TUBERCULOSIS TESTING Specimens/Tests/Reports
Nucleic Acid Amplification Test for Tuberculosis
Case discussion Michael Gardam University Health Network.
Infection Control Overview: TB Session 1: Infection Control Basics.
Sheboygan County 2013 Sandy Muesegades, RN – Public Health Nurse.
Group Exercise Infection Control of Aerosol Transmissible Diseases.
Outline Definition of isolation Principles of Isolation Isolation Policy Policy implementation Personnel Roles & Responsibilities Visitation.
ER NAVIGATOR Community Outreach for Personal Empowerment.
EBOLA Virus Disease August 22, What is Ebola Virus Disease (EVD)? Ebola virus disease (also known as Ebola hemorrhagic fever) is a severe, often-fatal.
Salmonella typhimurium Casey County, KY Jasie L. Jackson, MPH Regional Epidemiologist Epidemiology Rapid Response Team Fall Conference Sept
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
* TB is caused by a bacterium called Mycobacterium Tuberculosis. The bacteria usually attacks the lungs, but TB bacteria can attack any part of the.
Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.
1 Meeting with Contacts for TB Assessment. Learning Objectives After this session, participants will be able to: 1.Explain why contact assessments are.
Laboratory Training for Field Epidemiologists Strengthening Laboratory and Epidemiology Collaboration Introduction May 2007.
Us Case 5 Pulmonologist Referral with Lab, Radiation-Exposure-Monitored Imaging, and Drug Safety Reporting Interchange Care Theme: Transitions of Care.
Module 4: From Suspect to Confirmed Case. Learning Objectives Explain why sputum microscopy is important Describe the process for confirming a TB suspect.
D etection of E arly Lung C ancer A mong M ilitary P ersonnel Study 1 Version
1385 / 5 / 15 نشست سالانه برنامه كنترل سل شهريور Tuberculosis & Air Travel.
WHO local pilot projects to contain AMR ICIUM 2004 K.A.Holloway and T.L.Sorensen Essential Drugs and Medicines Policy WHO Geneva.
Tuberculosis in Ealing - Housing. What is TB Tuberculosis, or TB, is a disease caused by a germ (Mycobacterium tuberculosis). TB usually affects the lungs,
NYU Medical Grand Rounds Clinical Vignette Verity Schaye MD, PGY-2 February 3, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Event Notification Service
Tuberculosis Research of INA-RESPOND on Drug-resistant
TB Control Program County of San Diego Challenges: Cross border Continuity of TB Care Response:CureTBUS/Mexico Tuberculosis Referral and Information Program.
1 Module OVERVIEW OF EXTERNAL QUALITY ASSESSMENT.
Healthcare Institutions
Interoperability Showcase In collaboration with IHE Use Case 3 Care Theme: Leveraging National Healthcare Registries in Care Delivery Biosurveillance Monitoring.
Wisconsin State Laboratory of Hygiene. WISCONSIN STATE LABORATORY OF HYGIENE Case Study Youngmi Kim, MS, ASCP(M) Senior Microbiologist, Wisconsin State.
Progress of the Singapore TB Elimination Programme (STEP)
Elements of the Cohort Review Approach Harvey L. Marx, Jr. Lisa Schutzenhofer TB Program Controller TB Program Manager.
WISCONSIN STATE LABORATORY OF HYGIENE 1 State Lab Perspective Julie Tans-Kersten, MS, BS-MT (ASCP) Tuberculosis Laboratory Program Coordinator Wisconsin.
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
Port In Peril The following slides represent a realistic public health crisis event and you are charged with developing first messages for the public.
Improving Tuberculosis Infection Control
NAAT Is it Time for a New Option in California?. Background CDC 2009 guidelines recommend NAAT for each patient with suspected TB for whom the test result.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
The Epidemiology of Tuberculosis Lex Gibson, Virginia TB Program.
Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
GALVESTON COUNTY TB PROGRAM  SYED HAIDRY TB PROGRAM MANAGER  Dr. MARK GUIDRY CEO, HEALTH AUTHORITY & TB CLINICIAN.
Introduction to Contact Investigation Process Amy Schmitt, BSN, RN Public Health Grand Rounds Tuberculosis November 19, 2015.
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
LEARNING MODULE TITLE SUBTITLE. HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several.
©2016 Chamberlain College of Nursing, LLC. All rights reserved. 0114ccn MSN FNP Practicum Preparation.
Case Discussion 2 - TB IN CHILDREN by Dr. Jeyaseelan P. Nachiappan & Dr. Suryati Adnan 1 Picture of CPG Cover.
PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.
Management of the Newborn When Maternal TB Suspected
Antibiotics: handle with care!
Infection Control Q and A APIC Greater NY Chapter 13 May 17, 2017 Beth Nivin BA MPH NYC DOHMH Communicable Disease Program
Infant born with mother Tuberculosis
Outbreak Investigations
This is an archived document.
BECOMING AN ELEMENTARY TEACHER
This is an archived document.
Nucleic Acid Amplification Test for Tuberculosis
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Presentation 10 Analysing results and defining cases
What You Need to Know About Tuberculosis (TB)
Clinical microbiologists facing an anthrax alert
Epidemiological investigation of a nosocomial outbreak of multidrug-resistant Corynebacterium striatum at one Belgian university hospital  A. Verroken,
Using Whole Genome Sequencing Analysis in California
Interview Timeframes Conduct a minimum of 2 interviews: 1st interview
University of Washington
Presentation transcript:

MTB OUTBREAK LOCAL LAB RESPONSE Chris Partington MT(ASCP) ACL MICROBIOLOGY LAB

LOCAL LAB RESPONSE  ACL first specimens from outbreak: 04/20,21/2013 Sputums from daughter of index case Ordered for AFB culture/smear and MTD Both smear neg. One specimen MTD neg, one MTD pos. ACL unaware of “outbreak”, multiple contacts, relationship to index case. All the index case’s children have a different last name than the mother. Also unaware of probable resistant strain involved.  Five more specimens from 3 patients arrive in the next 4 days. All have the same last name, all children, all ordered for AFB culture/smear and MTD. At this point we have questions. We are informed by Sheboygan Public Health and WSLH that this is a possible outbreak situation.  ACL sends specimens (after decontamination and culture/smear performance) directly to WSLH for TB PCR testing due to the high MTD workload.

 After the first week of May 2013: The numbers of exposures, contacts and testing were exponentially increasing so we made the next change in protocol: Sheboygan Hospital would now send any samples related to the outbreak directly to WSLH.  We at ACL kept all work cards, communications, history/physicals and reports in a separate labeled folder for reference.  We were in almost daily communication with WSLH TB Lab, Sheboygan Public Health and Dr. Poursina (Infectious Disease) coordinating patients, specimens and tests.  We are still actively involved in all aspects because we have open accessions from the “in-house” cultures.

MISTAKES MADE / PROBLEMS ENCOUNTERED  Outbreak?! What outbreak? We had no clue that we were dealing with a possible outbreak; we were just seeing more than the usual orders for MTD. There were a few specimens with the same last name but it is a common one and we didn’t know the patients were related. No one alerted us to the possibility until we made some investigation.  Sure, we can handle that! No problem! We started with just a few specimens so we did it all: culture/smear and MTD. We were doing MTD’s daily which threw out our routine. We changed protocol a number of times: 1) Did all orders in–house 2) Did cultures/smears only and sent processed specimen to WSLH for TB PCR 3) Received specimen at our lab, then sent on to WSLH via our courier for all tests 4) Instructed Sheboygan lab to send all specimens directly to WSLH for testing This resulted in vast confusion: what tests are ours to result? how do we bill? who is getting the reports?

 Is it Racial Profiling or Cultural Understanding? Most of the offspring of the Index Case (“CM”) have a different last name from their mother. We did not know who was considered an “outbreak” contact and who was excluded. We received a tentative list of names from WSLH. We placed this list on the board in our specimen receiving area. We did not want these specimens manipulated outside of the TB room due to the MDR-TB designation. After a number of patient specimens came that were “outbreak” related but not on the list, we decided to consider all Hmong names from Sheboygan suspect. We learned surnames are not necessarily shared between families in the Hmong community. We learned a lot!  Unnecessary testing encountered. We had to watch the orders carefully. The children underwent bronchoscopies to obtain suitable specimens. The orders should have been for AFB cultures only but the specimens came with the “usual” bronch menu: AFB culture/smear, Fungus culture/smear, Routine culture/gram, pneumocystis testing. Why would they order a pneumocystis on a 14 yr.old? The explanation when questioned was that the pulmonologist just ordered his routine testing protocol!

WHAT WE’LL DO NEXT TIME (NEXT TIME?!)  Communication If possible set up more communication with key players: -Client (hospital Infection Control, outside lab personnel, clinic, etc.) -Public Heath -WSLH TB lab -appropriate Infectious Disease doc -our own Micro personnel  Education Have in-services with the Micro personnel about tuberculosis, outbreak situations, MDR-TB, the importance of carefully reviewing each specimen-name and test order. Urge personnel to investigate questionable orders, names, etc. and communicate with TB techs.  Diligence/Assertiveness/Demanding(?) Make sure everyone is doing their part. Don’t let the lab be the forgotten spoke of the wheel. Ask to be included on all communication. Keep your personnel informed.  Be mindful that specimens will keep coming for months (or years) for follow-up testing.

ACKNOWLEGEMENTS Julie Tans-Kersten WSLH TB Lab Sandy Musegades Sheboygan Public Health Dept. Dr. Arash Poursina Infectious Disease Teri Hosterman Sheboygan Memorial Infection Control Nancy Kapellen SMMC Lab Supervisor Fetije Shabanoski ACL Microbiology Supervisor